Summary
The product Dianabol 20 mg, manufactured by EQQ Remedies, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number VTS744, was submitted by the manufacturer EQQ Remedies (eqq-shop@protonmail.com) and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Methandienone, with concentrations of 25.31 mg, 26.22 mg, and 26.89 mg, exceeding the labeled claim of 20 mg.
The testing process was conducted on 15 November 2024. While the results indicate overdosing, scrutiny of manufacturer-submitted samples is essential to ensure reliability. Manufacturer may select specific batches that meet high-quality standards, raising questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: EQQ Remedies
- Product Name: Dianabol 20 mg
- Active Ingredient: Methandienone
- Batch Number: VTS744
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #52845
- Testing Ordered: 6 November 2024
- Sample Received: 15 November 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: EOQ Remedies (Manufacturer)
- Analysis Paid For By: EOQ Remedies (Manufacturer)
Testing Results
- Specification: 20 mg (as stated on the label)
- Measured Concentration: 25.31 mg; 26.22 mg; 26.89 mg
- Accuracy: 126.55% – 134.45% (exceeding the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/52845_VQPJ76U4ACJM
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the overdosing of the tested product but warrants careful evaluation due to its submission and funding by the manufacturer EQQ Remedies. Manufacturers often select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Dianabol 20 mg is overdosed, with measured concentrations of 25.31 mg, 26.22 mg, and 26.89 mg. This result reflects inconsistent quality control for this batch and underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
